Campbell'S vs Flowers Foods
CPB and FLO side by side, both in food and kindred products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CPB and FLO compare
Campbell'S is the larger company, worth 5.0 times as much as Flowers Foods ($6.7B against $1.3B).
On earnings, Campbell'S is cheaper: it trades at 17.0× trailing earnings, against 24.0× for Flowers Foods.
Flowers Foods grew revenue faster over the last twelve months (2.5% versus −5.0% for Campbell'S).
Campbell'S keeps more of each dollar of sales as profit, with a net margin of 4.1% compared with 1.1% at Flowers Foods.
Both pay dividends: Campbell'S yields 6.4% and Flowers Foods 11.9%.
Flowers Foods scores higher on the StockData Score (14 against 11 for Campbell'S), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CPB | FLO |
|---|---|---|
| Size and price | ||
| Market cap | $6.7B | $1.3B |
| Share price | $22.31 | $6.25 |
| Change, 1 year | −27.2% | −45.0% |
| Change, 5 years | −45.0% | −76.7% |
| Beta (5Y) | 0.09 | 0.22 |
| Employees | 14K | 10K |
| StockData Score | ||
| Total score | 11 | 14 (better) |
| Valuation score | 4 | 5 (better) |
| Growth score | 0 | 1 (better) |
| Performance score | 2 | 2 |
| Health score | 0 | 1 (better) |
| Dividend score | 5 | 5 |
| Valuation | ||
| P/E | 17.0× (better) | 24.0× |
| P/S | 0.7× | 0.3× (better) |
| P/B | 1.7× | 1.0× (better) |
| EV/EBITDA | 10.6× | 9.5× (better) |
| P/FCF | 9.8× | 4.3× (better) |
| FCF yield | 10.2% | 23.1% (better) |
| Fair value | $28.44 | $11.04 |
| Margin of safety | 21.6% | 43.4% (better) |
| Growth | ||
| Revenue growth (TTM) | −5.0% | 2.5% (better) |
| Revenue growth, 5Y average | 2.8% | 3.7% (better) |
| Net income growth (TTM) | −33.1% (better) | −74.9% |
| EPS growth (TTM) | −34.8% (better) | −75.0% |
| EPS growth, 5Y average | −16.8% | −11.1% (better) |
| Profitability | ||
| Gross margin | 28.1% | 48.6% (better) |
| Operating margin | 8.7% (better) | 2.7% |
| Net margin | 4.1% (better) | 1.1% |
| FCF margin | 7.0% (better) | 5.9% |
| Return on equity | 10.4% (better) | 4.0% |
| Return on invested capital | 6.1% (better) | 3.2% |
| Financial health | ||
| Debt / equity | 1.85 | 1.27 (better) |
| Net debt / EBITDA | 5.33 | 5.23 (better) |
| Interest coverage | 2.6× (better) | 1.8× |
| Current ratio | 0.82 (better) | 0.77 |
| Altman Z-score | 1.52 | 1.86 (better) |
| Piotroski F-score | 6 (better) | 5 |
| Dividends and buybacks | ||
| Dividend yield | 6.4% | 11.9% (better) |
| Payout ratio | 117% | 336% |
| Years of dividend growth | 2 | 17 (better) |
| Dividend growth, 5Y average | 1.3% | 4.5% (better) |
| Buyback yield | 0.39% (better) | 0.29% |
| Shareholder yield | 6.8% | 12.2% (better) |
| Ownership | ||
| Held by institutions | 62.1% | 104% |
| Held by insiders | 38.5% | 7.0% |
| Insider net buying, 12 months | −$390K (better) | −$3.9M |
| Superinvestors holding | 1 | – |
| Short interest, % of float | 21.1% | 25.7% |
Go deeper
- CPB stock overview
- CPB income statement
- CPB valuation and score
- FLO stock overview
- FLO income statement
- FLO valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.